Last reviewed · How we verify
NCT07000591: Massage Based
Massage Based on the Human Caring Model in Epilepsy
NA trial testing Experimental Group in Epilepsy in 96 participants. Completed in 15 September 2025.
15 June 2025
Quick facts
| Lead sponsor | Muş Alparslan University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 96 |
| Start date | 15 June 2025 |
| Primary completion | 15 June 2025 |
| Estimated completion | 15 September 2025 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Experimental Group
Conditions studied
- Epilepsy — all drugs for Epilepsy →
Sponsor
Muş Alparslan University
Who can join
Adults 18 to 65, any sex, with Epilepsy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized controlled study will be conducted with 96 epilepsy patients and their caregivers at Atatürk University Research Hospital between November 2024 and February 2026. Participants will be randomly assigned to experimental and control groups. The experimental group will receive neck massage based on Jean Watson's Human Caring Model three times a week for eight weeks. Data will be collected using various scales to evaluate self-efficacy, symptom management, and caregiver burden before and after the intervention.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07000591
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Experimental Group
Trials testing the same drug.
- NCT07511894 — Beta-Blockers on the Efficacy of Neoadjuvant Immunotherapy for Gastric Cancer · Phase 2 · not yet recruiting
- NCT07505472 — Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Wit · Phase 2, PHASE3 · recruiting
- NCT07316946 — Effects of Neuromuscular Taping on Shoulder Pain and Function in Pitchers: A Clinical Trial · NA · not yet recruiting
- NCT07125820 — A Dual Intervention in Migraine Treatment: Tens and Exercise · NA · not yet recruiting
- NCT07514637 — Safety and Efficacy of Anricfen for Postoperative Analgesia and Rehabilitation Promotion After Pancreaticoduodenectomy.I · Phase 2 · recruiting
Other recruiting trials for Epilepsy
Currently open trials in the same condition.
- NCT07095933 — The Safety and Efficacy Evaluation of Everolimus as an Adjunctive Treatment for Focal Refractory Epilepsy · EARLY_PHASE1 · recruiting
- NCT07224191 — Hippocampal Oscillations During Exploration · NA · recruiting
- NCT07219407 — A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset Seizures · Phase 2 · recruiting
- NCT07417280 — LIFUS For Neurological Disorders · NA · recruiting
- NCT07490769 — Levetiracetam Three Times Daily in Epilepsy · Phase 3 · recruiting
Other Muş Alparslan University trials
Trials by the same sponsor.
- NCT07507695 — Acute Effects of Patellar Tendon Ultrasound on Countermovement Jump Performance · NA · not yet recruiting
- NCT07297628 — Teaching Caring Through '1 Concept-1 Minute · NA · not yet recruiting
- NCT07397221 — Oropharyngeal Humidification After Extubation on Thirst · NA · not yet recruiting
- NCT07355244 — Self-Affirmation Intervention After Mastectomy · NA · not yet recruiting
- NCT07274553 — Mindfulness-Based Stress Reduction for Adolescents: Effects on Game Addiction, Stress, and Sleep · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07000591 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Muş Alparslan University
- Last refreshed: 1 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07000591.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing